Skip to content

The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients

The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04402983
Enrollment
34
Registered
2020-05-27
Start date
2020-05-27
Completion date
2020-12-01
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Physical Therapy, Telerehabilitation

Keywords

exercise, videoconference

Brief summary

Problems such as breathlessness, exercise intolerance and loss of peripheral muscle strength can be observed in individuals who have been diagnosed with COVID19 and have been discharged. In our study, it was aimed to investigate the effect of telerehabilitation physical therapy intervention to these cases by using videoconferencing method on the physical condition of the cases.

Detailed description

Problems such as breathlessness, exercise intolerance and loss of peripheral muscle strength can be observed in individuals who have been diagnosed with COVID19 and have been discharged. In our study, it was aimed to investigate the effect of telerehabilitation physical therapy intervention to these cases by using videoconferencing method on the physical condition of the cases. The exercise program will be a total of 6 weeks, 3 days a week. Online access will be carried out synchronously by telephone or computer, and training sessions will not be recorded in order to protect patient personal information. The cases will be evaluated online at the beginning of the study and at the end of the 6-week exercise program. The selected evaluation parameters have been selected considering the ease of online application.

Interventions

OTHERPhysiotherapy

Program content Respiratory exercise (chest breathing, diaphragmatic breathing, basal expansion exercises), Breath control training, Active breathing techniques cycle Light aerobic exercise Posture exercises Self walking

Sponsors

Istanbul Medipol University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized controlled clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Being between the ages of 18-75 * Being diagnosed with COVID19 and being discharged by being treated * Having technological facilities suitable for telerehabilitation access

Exclusion criteria

* Any presence of comorbidity that may prevent them from exercising * Not agreeing to be included in the study

Design outcomes

Primary

MeasureTime frameDescription
Timed up and go testBaseline to 6 weeksThe Timed Up and Go (TUG) Test measures, in seconds, the time taken by an individual to stand up from a standard arm chair (approximate seat height of 46 cm, arm height 65 cm), walk a distance of 3 meters (approximately 10 feet), turn, walk back to the chair, and sit down. Normal healthy elderly usually complete the task in 10 seconds or less. Very frail or weak elderly with poor mobility may take 2 minutes or more. Clinical guide: \<10 seconds = normal \<20 seconds = good mobility, can go out alone, mobile without a gait aid \<30 seconds = problems, cannot go outside alone, requires a gait aid A score of more than or equal to 14 seconds has been shown to indicate high risk of falls.
The Short Physical Performance Battery (SPPB)Baseline to 6 weeksThe Short Physical Performance Battery (SPPB) is comprised of 3 tasks: a standing balance test (side by side, semi-tandem and tandem), a 4-m habitual gait speed, and 5 sit to stand from a chair. Each task is scored (based on time) from 0-4 points. The total score is 12 points and this represents the highest performance. It can be easily performed at home via video conferencing
Visual analog scale to assess the fatigue severityBaseline to 6 weeksVisual analog scale to assess the fatigue severity on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100) score.
Modified Medical Research Council Dyspnea ScoreBaseline to 6 weeksThe mMRC Dyspnea Scale is best used to establish baseline functional impairment due to dyspnea attributable to respiratory disease; tracking the mMRC over time or with therapeutic interventions is of less certain clinical utility.The severity of dyspnea is rated on a scale of 0 to 4. O means no dyspnea perception, 4 means severe dyspnea perception.
Visual analog scale to assess the pain severityBaseline to 6 weeksVisual analog scale to assess the pain on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100) score.

Secondary

MeasureTime frameDescription
Saint George Respiratory QuestionnaireBaseline to 6 weeksThe SGRQ ranges from 0 (no impairment of quality of life) to 100 (highest impairment of quality of life)
BECK depression inventoryBaseline to 6 weeksThis is a 21-item self-assessment scale designed by Aaron Beck in 1961 to measure the risk and level of depression.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026